DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Phase 2 study of ipilimumab in children and adolescents (12 to <18 years) with previously treated or untreated, unresectable stage III or stage IV malignant melanoma.
Available at:
https://clinicaltrials.gov/ct2/show/NCT01696045
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.